"...R&D expenditures (again, as a per cent of sales) rose in the 1980s, were flat in the 1990s, and have risen since then. Overall, since 1975, the proportion of money spent on R&D has more than tripled, from 5% to 17%.
This, I hardly need point out, does not fit the narrative of some of the e-mails and comments I get. Some perceptions of the drug industry have us, Back In the Old Days, as spending our money on R&D, only to slimily slide into becoming pure marketing businesses as time has passed, with our recent years being especially disgusting and rapacious. According to these figures, this is at the very least not accurate, and comes close to being the opposite of the truth..."
pipeline.corante.com
12. Dylan on July 8, 2009 9:22 AM writes...
The 40% number is for all SG&A (Selling, General and Administrative) expenses and includes more than just sales and marketing, pretty much everything that isn't a direct input to R&D or production gets lumped in to SG&A.
pipeline.corante.com |
